Jefferies Group’s Immunomedics Inc IMMU Stock Holding History

Jefferies Group’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-160,160	Closed	-$13.6M	–	1933
2020 Q3	$13.6M	Buy	+160,160	New	+$8.1M	0.15%	95
2020 Q1	–	Sell	-8,663	Closed	-$183K	–	2894
2019 Q4	$183K	Buy	+8,663	New	+$153K	﹤0.01%	2279
2019 Q3	–	Sell	-9,925	Closed	-$146K	–	3201
2019 Q2	$138K	Buy	+9,925	New	+$149K	﹤0.01%	2227
2016 Q4	–	Sell	-20,409	Closed	-$66K	–	2601
2016 Q3	$66K	Sell	20,409 -17,391	-46%	-$48.6K	﹤0.01%	2072
2016 Q2	$88K	Buy	+37,800	New	+$126K	﹤0.01%	1952

Jefferies Group's IMMU Position: Q4 2020 in Review

Jefferies Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 160,160 shares — an estimated $13.6M sold.

Jefferies Group first reported a position in IMMU in Q2 2016 and held it in 5 quarters. The position peaked at $13.6M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Jefferies Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Jefferies Group sold 160,160 Immunomedics Inc shares in Q4 2020, an estimated $13.6M.
Jefferies Group first reported a position in Immunomedics Inc in Q2 2016 and held it in 5 quarters.
Jefferies Group's Immunomedics Inc position peaked at $13.6M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Jefferies Group's 13F filing for Q4 2020, filed 16 Feb 2021.